Published in Nature on March 26, 2009
Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol (2009) 8.85
Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol (2009) 4.62
A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics (2011) 4.40
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov (2010) 2.90
mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol (2013) 2.73
The cullin protein family. Genome Biol (2011) 2.43
The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol (2011) 2.15
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer (2010) 1.97
Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal (2010) 1.85
Protein standard absolute quantification (PSAQ) method for the measurement of cellular ubiquitin pools. Nat Methods (2011) 1.60
Regulation of proteasome activity in health and disease. Biochim Biophys Acta (2013) 1.52
A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34
Regulation of Akt signaling activation by ubiquitination. Cell Cycle (2010) 1.28
Posttranslational regulation of Akt in human cancer. Cell Biosci (2014) 1.27
Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development. Oncogene (2010) 1.21
Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat Struct Mol Biol (2013) 1.20
Ubiquitin regulates GGA3-mediated degradation of BACE1. J Biol Chem (2010) 1.16
Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS One (2011) 1.14
Characterization of cell cycle specific protein interaction networks of the yeast 26S proteasome complex by the QTAX strategy. J Proteome Res (2010) 1.14
Proteasomes and protein conjugation across domains of life. Nat Rev Microbiol (2011) 1.12
HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation. PLoS Pathog (2014) 1.10
UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity. Proc Natl Acad Sci U S A (2011) 1.09
The two faces of FBW7 in cancer drug resistance. Bioessays (2011) 1.08
Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity. Nat Commun (2014) 1.08
Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues. J Biol Chem (2011) 1.08
New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. Am J Pathol (2012) 1.08
ER-Golgi network--a future target for anti-cancer therapy. Leuk Res (2009) 1.08
Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer (2012) 1.06
Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol (2011) 1.05
Brain region-specific gene expression changes after chronic intermittent ethanol exposure and early withdrawal in C57BL/6J mice. Addict Biol (2011) 1.05
From bortezomib to other inhibitors of the proteasome and beyond. Curr Pharm Des (2013) 1.04
Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell (2012) 1.04
Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem (2011) 1.04
Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling. EMBO J (2012) 1.03
IAPs: guardians of RIPK1. Cell Death Differ (2011) 1.03
Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Gastroenterology (2011) 1.00
Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis. Biochim Biophys Acta (2014) 1.00
E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin. Nat Chem Biol (2013) 0.98
Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo. Oncotarget (2015) 0.98
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skelet Muscle (2011) 0.94
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications. EMBO Mol Med (2012) 0.94
Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol Cell Biol (2011) 0.93
Retracted Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain. EMBO Rep (2011) 0.93
Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol Ther (2010) 0.93
The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis. Int J Clin Exp Pathol (2012) 0.92
USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma. PLoS One (2012) 0.92
Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nat Cell Biol (2015) 0.92
VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells. PLoS One (2013) 0.91
It takes two to tango: Ubiquitin and SUMO in the DNA damage response. Front Genet (2013) 0.90
The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR. Blood (2016) 0.90
Airway Exposure to E-Cigarette Vapors Impairs Autophagy and Induces Aggresome Formation. Antioxid Redox Signal (2015) 0.89
USP22 regulates oncogenic signaling pathways to drive lethal cancer progression. Cancer Res (2013) 0.88
Two nuclear localization signals in USP1 mediate nuclear import of the USP1/UAF1 complex. PLoS One (2012) 0.88
The regulation of TGF-β/SMAD signaling by protein deubiquitination. Protein Cell (2014) 0.88
K63-linked ubiquitination in kinase activation and cancer. Front Oncol (2012) 0.87
The role of proteasome inhibition in nonsmall cell lung cancer. J Biomed Biotechnol (2011) 0.87
Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen. J Biol Chem (2012) 0.87
USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy. Mol Cancer (2013) 0.87
Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models. J Exp Clin Cancer Res (2014) 0.87
The E3 ubiquitin ligase XIAP restricts Anaplasma phagocytophilum colonization of Ixodes scapularis ticks. J Infect Dis (2013) 0.87
An apicoplast localized ubiquitylation system is required for the import of nuclear-encoded plastid proteins. PLoS Pathog (2013) 0.86
Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (e1). PLoS One (2012) 0.86
FAT10 protein binds to polyglutamine proteins and modulates their solubility. J Biol Chem (2011) 0.86
Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells. Mini Rev Med Chem (2012) 0.86
HUWE1 interacts with PCNA to alleviate replication stress. EMBO Rep (2016) 0.86
Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep (2010) 0.86
Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis. J Biol Chem (2012) 0.86
Role of E3 ubiquitin ligases in lung cancer. World J Clin Oncol (2013) 0.86
Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study. PLoS One (2011) 0.86
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Rep (2016) 0.84
Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'. Anticancer Res (2011) 0.84
Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system. Trends Immunol (2012) 0.84
Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins. Mol Cell Proteomics (2013) 0.84
USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition. Int J Mol Sci (2014) 0.84
Ubiquitin-specific protease 4 inhibits mono-ubiquitination of the master growth factor signaling kinase PDK1. PLoS One (2012) 0.83
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget (2014) 0.83
TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor. Cell Cycle (2015) 0.82
Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways. Int J Mol Sci (2012) 0.82
The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. Mol Cell (2016) 0.82
Downregulation of ubiquitin level via knockdown of polyubiquitin gene Ubb as potential cancer therapeutic intervention. Sci Rep (2013) 0.82
Targeting ubiquitination for cancer therapies. Future Med Chem (2015) 0.82
Genome-wide approaches to systematically identify substrates of the ubiquitin-proteasome pathway. Trends Biotechnol (2010) 0.81
Proteomic identification of protein ubiquitination events. Biotechnol Genet Eng Rev (2013) 0.81
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation. Cell Rep (2015) 0.81
Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. Dig Dis Sci (2015) 0.81
Loss of Trabid, a new negative regulator of the drosophila immune-deficiency pathway at the level of TAK1, reduces life span. PLoS Genet (2014) 0.81
Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer. Genome Med (2016) 0.81
Adjuvant activity of GP96 C-terminal domain towards Her2/neu DNA vaccine is fusion direction-dependent. Cell Stress Chaperones (2010) 0.80
The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer. Oncogenesis (2012) 0.80
Identification of factors that function in Drosophila salivary gland cell death during development using proteomics. Cell Death Differ (2012) 0.80
Novel strategies to target the ubiquitin proteasome system in multiple myeloma. Oncotarget (2016) 0.80
Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol (2013) 0.80
Screening of potential molecular targets for colorectal cancer therapy. Int J Gen Med (2009) 0.80
Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome. Cell Death Dis (2015) 0.80
Myc proteins in brain tumor development and maintenance. Ups J Med Sci (2012) 0.80
Mini-chaperones: potential immuno-stimulators in vaccine design. Hum Vaccin Immunother (2012) 0.79
Proteomics for systems toxicology. Comput Struct Biotechnol J (2014) 0.79
Novel genetic analysis in Behçet's disease. Arthritis Res Ther (2009) 0.79
Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. J Biol Chem (2015) 0.79
Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol (2015) 0.79
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Mechanisms underlying ubiquitination. Annu Rev Biochem (2001) 18.87
Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol (2002) 10.12
A genomic and functional inventory of deubiquitinating enzymes. Cell (2005) 9.36
Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol (2005) 8.06
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell (2007) 7.74
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer (2006) 7.53
Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer (2006) 6.76
Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science (2007) 6.65
Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep (2008) 6.21
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer (2008) 6.10
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol (2008) 5.90
Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science (2005) 5.75
Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell (2007) 5.62
p53 ubiquitination: Mdm2 and beyond. Mol Cell (2006) 5.57
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med (2004) 5.48
Ubiquitin-binding domains. Biochem J (2006) 5.32
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell (2007) 5.20
Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature (2008) 4.76
Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol (2008) 4.68
Ubiquitylation and cell signaling. EMBO J (2005) 4.65
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem (2001) 4.51
The development of proteasome inhibitors as anticancer drugs. Cancer Cell (2004) 4.46
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell (2006) 4.43
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell (2005) 4.40
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature (2007) 4.14
MDM2 inhibitors for cancer therapy. Trends Mol Med (2006) 3.88
IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol (2005) 3.68
IAPs: what's in a name? Mol Cell (2008) 3.66
The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol (2007) 3.63
Deubiquitylation and regulation of the immune response. Nat Rev Immunol (2008) 3.59
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem (2008) 3.54
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature (2008) 3.53
The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell (2008) 3.35
Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov (2006) 3.27
MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets (2005) 3.04
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer (2006) 2.90
Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol (2005) 2.88
Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res (2007) 2.50
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science (2004) 2.50
P53 and prognosis: new insights and further complexity. Cell (2005) 2.28
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res (2007) 2.19
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell (2005) 2.17
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell (2008) 2.12
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol (2007) 1.94
Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol (2004) 1.90
Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol (2007) 1.90
Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood (2007) 1.89
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells. Blood (2007) 1.86
Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol (2003) 1.85
The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci U S A (2008) 1.78
Proteolysis. The proteasome: a protein-degrading organelle? Curr Biol (1995) 1.74
Role of proteasomes in disease. BMC Biochem (2007) 1.65
Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J Clin Invest (2005) 1.55
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. Blood (2007) 1.54
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res (2003) 1.47
DNA damage: ubiquitin marks the spot. Nat Struct Mol Biol (2008) 1.43
Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J Biol Chem (2007) 1.37
Bortezomib in the front-line treatment of multiple myeloma. Expert Rev Anticancer Ther (2008) 1.36
Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle (2007) 1.26
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer. J Med Chem (2008) 1.22
A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions. J Biol Chem (2007) 1.22
Patented small molecule inhibitors in the ubiquitin proteasome system. BMC Biochem (2007) 1.19
Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells. Mol Cancer Ther (2008) 1.04
Monoubiquitination: the signal for p53 nuclear export? Cell Cycle (2004) 1.02
Alternative UPS drug targets upstream the 26S proteasome. Int J Biochem Cell Biol (2007) 1.00
Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes. BMC Biochem (2007) 0.99
Effect of an hdm-2 antagonist peptide inhibitor on cell cycle progression in p53-deficient H1299 human lung carcinoma cells. Oncogene (2006) 0.89
Proteasome inhibitor, bortezomib, for myeloma and lymphoma. Int J Clin Oncol (2007) 0.86
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A role for ubiquitin in selective autophagy. Mol Cell (2009) 8.43
A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell (2009) 6.88
Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep (2008) 6.21
Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell (2009) 5.76
Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science (2005) 5.75
Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep (2009) 5.52
Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science (2011) 5.46
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol (2003) 5.43
Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature (2008) 4.76
Ubiquitylation and cell signaling. EMBO J (2005) 4.65
Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol (2006) 4.55
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature (2011) 4.14
Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature (2002) 3.99
Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem (2006) 3.59
Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem Sci (2003) 3.37
The Cbl interactome and its functions. Nat Rev Mol Cell Biol (2005) 3.27
Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature (2008) 3.11
Regulation of ubiquitin-binding proteins by monoubiquitination. Nat Cell Biol (2006) 2.99
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer (2006) 2.90
E3-independent monoubiquitination of ubiquitin-binding proteins. Mol Cell (2007) 2.77
Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem (2012) 2.53
Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr Opin Cell Biol (2007) 2.30
Post-translational modifications in signal integration. Nat Struct Mol Biol (2010) 2.23
The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol (2011) 2.15
NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle (2009) 2.12
Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat Cell Biol (2011) 2.07
Spatial organization of transmembrane receptor signalling. EMBO J (2010) 2.03
Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol Cell Biol (2006) 2.02
Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood (2007) 1.99
Fluorescence-based sensors to monitor localization and functions of linear and K63-linked ubiquitin chains in cells. Mol Cell (2012) 1.94
Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe (2012) 1.93
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat Methods (2013) 1.88
Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J (2008) 1.87
What determines the specificity and outcomes of ubiquitin signaling? Cell (2010) 1.84
Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol Cell (2010) 1.84
The role of ubiquitylation in receptor endocytosis and endosomal sorting. J Cell Sci (2012) 1.73
Caspase-8 is involved in neovascularization-promoting progenitor cell functions. Arterioscler Thromb Vasc Biol (2009) 1.70
Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol (2004) 1.67
Generation and physiological roles of linear ubiquitin chains. BMC Biol (2012) 1.66
Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood (2008) 1.58
Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. Chem Rev (2009) 1.56
Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal (2009) 1.54
Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J (2007) 1.51
Contributions of ubiquitin- and PCNA-binding domains to the activity of Polymerase eta in Saccharomyces cerevisiae. Nucleic Acids Res (2007) 1.49
Rab GTPase-activating proteins in autophagy: regulation of endocytic and autophagy pathways by direct binding to human ATG8 modifiers. Mol Cell Biol (2012) 1.48
NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy (2009) 1.46
Signal processing by its coil zipper domain activates IKK gamma. Proc Natl Acad Sci U S A (2008) 1.46
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J (2012) 1.45
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proc Natl Acad Sci U S A (2010) 1.45
The Three Musketeers of Autophagy: phosphorylation, ubiquitylation and acetylation. Trends Cell Biol (2011) 1.43
Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem (2003) 1.41
Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc Natl Acad Sci U S A (2002) 1.40
Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem (2004) 1.38
Human Wrnip1 is localized in replication factories in a ubiquitin-binding zinc finger-dependent manner. J Biol Chem (2008) 1.37
CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem (2002) 1.36
CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell (2004) 1.34
The LC3 interactome at a glance. J Cell Sci (2013) 1.34
Mitophagy in yeast is independent of mitochondrial fission and requires the stress response gene WHI2. J Cell Sci (2011) 1.30
Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci (2012) 1.30
Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal. Nat Cell Biol (2009) 1.29
Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem (2012) 1.29
Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol (2005) 1.25
Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol Chem (2010) 1.24
Mitochondria get a Parkin' ticket. Nat Cell Biol (2010) 1.22
Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci (2004) 1.20
Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. J Biol Chem (2012) 1.20
Characterization of the interaction of GABARAPL-1 with the LIR motif of NBR1. J Mol Biol (2011) 1.11
Requirements for the interaction of mouse Polkappa with ubiquitin and its biological significance. J Biol Chem (2007) 1.11
Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb Perspect Biol (2014) 1.10
Ubiquitin networks in cancer. Curr Opin Genet Dev (2010) 1.06
TBC1D5 and the AP2 complex regulate ATG9 trafficking and initiation of autophagy. EMBO Rep (2014) 1.06
Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal (2008) 1.06
Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y family DNA polymerases iota and Rev1. Mol Cell (2010) 1.05
Cbl promotes clustering of endocytic adaptor proteins. Nat Struct Mol Biol (2005) 1.05
Structural basis for phosphorylation-triggered autophagic clearance of Salmonella. Biochem J (2013) 1.03
Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem (2005) 1.03
Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J Biol Chem (2004) 1.02
Cindr interacts with anillin to control cytokinesis in Drosophila melanogaster. Curr Biol (2010) 1.02
Receptor endocytosis via ubiquitin-dependent and -independent pathways. Biochem Pharmacol (2004) 1.02
Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem J (2003) 1.01
SH3P2 in complex with Cbl and Src. FEBS Lett (2004) 1.00
Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases. FEBS Lett (2007) 1.00
Autophagy receptors in developmental clearance of mitochondria. Autophagy (2011) 0.99
Childhood of a phoenix: modern biology in Eastern and South-Eastern Europe. Nat Rev Mol Cell Biol (2008) 0.99
Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep (2005) 0.97
Atypical polyproline recognition by the CMS N-terminal Src homology 3 domain. J Biol Chem (2006) 0.97
CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. EMBO J (2010) 0.96
CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. J Immunol (2005) 0.96
The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice. PLoS Genet (2009) 0.95
Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem (2002) 0.94
Structural analysis of SHARPIN, a subunit of a large multi-protein E3 ubiquitin ligase, reveals a novel dimerization function for the pleckstrin homology superfold. J Biol Chem (2012) 0.94
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications. EMBO Mol Med (2012) 0.94
CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem (2007) 0.93
Dab2 links CIN85 with clathrin-mediated receptor internalization. FEBS Lett (2003) 0.93
Not all autophagy membranes are created equal. Cell (2010) 0.92
Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells. Mol Cell Endocrinol (2002) 0.90
Ubiquitin hubs in oncogenic networks. Mol Cancer Res (2006) 0.89
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor. Biochem Biophys Res Commun (2003) 0.89